S-adenosyl-L-methionine for alcoholic liver diseases (Q24246175)

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Effect of S-adenosyl-L-methionine administration on plasma levels of sulphur-containing amino acids in patients with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Reversal of extrahepatic membrane cholesterol deposition in patients with chronic liver diseases by S-adenosyl-L-methionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Chemistry and biology of DNA methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Polyenylphosphatidylcholine corrects the alcohol-induced hepatic oxidative stress by restoring s-adenosylmethionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Transcranial electrical stimulation in patients with apallic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

THE NATURE OF THE ACTIVE METHYL DONOR FORMED ENZYMATICALLY FROM L-METHIONINE AND ADENOSINETRIPHOSPHATE1,2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Inhibition of liver methionine adenosyltransferase gene expression by 3-methylcolanthrene: protective effect of S-adenosylmethionine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Practical aspects in data monitoring: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Ethanol-induced changes in methionine metabolism in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Quality assessment of reports on clinical trials in the Journal of Hepatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Evidence based medicine in LIVER

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Randomized clinical trials in HEPATOLOGY: predictors of quality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Funding, disease area, and internal validity of hepatobiliary randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Validity of randomized clinical trials in gastroenterology from 1964–2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

II. Veterans Affairs Cooperative Study of Polyenylphosphatidylcholine in Alcoholic Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

S-adenosylmethionine synthesis: molecular mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

A consumer's guide to subgroup analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Alcohol-induced hepatic injury in nonalcoholic volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Pharmacologic aspects of S-adenosylmethionine. Pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: A multicenter sequential trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Do certain countries produce only positive results? A systematic review of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Metabolism of exogenous S-adenosyl-L-methionine in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

S-adenosyl-L-methionine for alcoholic liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

7 January 2021

Modulation by S-Adenosyl-L-Methionine of Hepatic Na+, K+-ATPase, Membrane Fluidity, and Bile Flow in Rats with Ethinyl Estradiol-Induced Cholestasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

7 January 2021

S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

7 January 2021

Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

7 January 2021

Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

7 January 2021

Variations of plasma apoliporpoteins AI and B induced in liver patients by infusions of S-adenosyl-L-methionine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

7 January 2021

Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

7 January 2021

Role of S-adenosyl-L-methionine in the treatment of liver diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

7 January 2021

Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

7 January 2021

S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

7 January 2021

S-adenosylmethionine blood levels in major depression: changes with drug treatment.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

7 January 2021

An experimental model of alcohol feeding and liver injury in the baboon

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002235.PUB2

7 January 2021